Value of transrectal contrast-enhanced ultrasound with clinical indicators in the prediction of bone metastasis in prostate cancer.

Hong, Hua; Liang, Danyan; Liu, Qian; Wu, Guozhu; Sun, Ran; Liu, Juzhen; Wang, Feng; Wang, Fang

Hong, Hua; Liang, Danyan; Liu, Qian; Wu, Guozhu; Sun, Ran; Liu, Juzhen; Wang, Feng; Wang, Fang.

Afiliação

Hong H; Department of Ultrasonography, Inner Mongolia People's Hospital, Hohhot, China.
Liang D; Department of Ultrasonography, Inner Mongolia People's Hospital, Hohhot, China.
Liu Q; Department of Ultrasonography, Inner Mongolia People's Hospital, Hohhot, China.
Wu G; Department of Ultrasonography, Inner Mongolia People's Hospital, Hohhot, China.
Sun R; Department of Ultrasonography, Inner Mongolia People's Hospital, Hohhot, China.
Liu J; Department of Nuclear Medicine, Inner Mongolia People's Hospital, Hohhot, China.
Wang F; Department of Pathology, Inner Mongolia People's Hospital, Hohhot, China.
Wang F; Department of Ultrasonography, Inner Mongolia People's Hospital, Hohhot, China.

Quant Imaging Med Surg ; 12(3): 1750-1761, 2022 Mar.

Article em En | MEDLINE | ID: mdl-35284288

Palavras-chave

Prostate cancer (PCa); alkaline phosphatase (ALP); bone metastasis; total prostate-specific antigen (TPSA); transrectal contrast-enhanced ultrasound (TR-CEUS)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Quant Imaging Med Surg Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google